In Vivo and Ex Vivo Inhibition of Spinal Nerve Ligation-Induced Ectopic Activity by Sodium Channel Blockers Correlate to In Vitro Inhibition of NaV1.7 and Clinical Efficacy: A Pharmacokinetic-Pharmacodynamic Translational Approach
- 1 February 2013
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 30 (5) , 1409-1422
Abstract
In vivo and ex vivo inhibition of ectopic activity of clinically used and newly developed sodium channel (NaV) blockers were quantified in the rat spinal nerve ligation (SNL) model using a pharmacokinetic-pharmacodynamic (PKPD) approach and correlated to in vitro NaV1.7 channel inhibition and clinical effective concentrations.Keywords
This publication has 41 references indexed in Scilit:
- Effect of local and intravenous lidocaine on ongoing activity in injured afferent nerve fibersPain, 2011
- Phenyl isoxazole voltage-gated sodium channel blockers: Structure and activity relationshipBioorganic & Medicinal Chemistry Letters, 2011
- The Effect of Amitriptyline on Ectopic Discharge of Primary Afferent Fibers in the L5 Dorsal Root in a Rat Model of Neuropathic PainAnesthesia & Analgesia, 2009
- Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerationsDrug Discovery Today, 2009
- Sodium channels and nociception: recent concepts and therapeutic opportunitiesCurrent Opinion in Pharmacology, 2008
- A stop codon mutation in SCN9A causes lack of pain sensationHuman Molecular Genetics, 2007
- Blocking sodium channels to treat neuropathic painExpert Opinion on Therapeutic Targets, 2007
- SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and PhenotypesNeuron, 2006
- Translating Basic Research on Sodium Channels in Human Neuropathic PainThe Journal of Pain, 2006
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993